Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Bone Mineral Density After Transitioning From Denosumab to Alendronate.

Kendler D, Chines A, Clark P, Ebeling PR, McClung M, Rhee Y, Huang S, Stad RK.

J Clin Endocrinol Metab. 2020 Mar 1;105(3). pii: dgz095. doi: 10.1210/clinem/dgz095.

2.

Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom.

Svedbom A, Hadji P, Hernlund E, Thoren R, McCloskey E, Stad R, Stollenwerk B.

Osteoporos Int. 2019 Sep;30(9):1745-1754. doi: 10.1007/s00198-019-05064-w. Epub 2019 Jul 3.

PMID:
31270592
3.

Gene expression profiling of suppressor mechanisms in tuberculosis.

Smit van Dixhoorn MG, Munir R, Sussman G, Stad R, de Haan M, van der Hoeven T, Rauwerda H, Breit TM, Thallinger GG, Wadee AA.

Mol Immunol. 2008 Mar;45(6):1573-86.

PMID:
18068800
4.

Dynamic changes of proteases and protease inhibitors revealed by microarray analysis in CA3 and entorhinal cortex during epileptogenesis in the rat.

Gorter JA, Van Vliet EA, Rauwerda H, Breit T, Stad R, van Schaik L, Vreugdenhil E, Redeker S, Hendriksen E, Aronica E, Lopes da Silva FH, Wadman WJ.

Epilepsia. 2007;48 Suppl 5:53-64. Erratum in: Epilepsia. 2007 Dec;48(12):2379.

5.

Critical role for a central part of Mdm2 in the ubiquitylation of p53.

Meulmeester E, Frenk R, Stad R, de Graaf P, Marine JC, Vousden KH, Jochemsen AG.

Mol Cell Biol. 2003 Jul;23(14):4929-38.

6.

Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms.

Stad R, Little NA, Xirodimas DP, Frenk R, van der Eb AJ, Lane DP, Saville MK, Jochemsen AG.

EMBO Rep. 2001 Nov;2(11):1029-34. Epub 2001 Oct 17.

7.

Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53.

Ramos YF, Stad R, Attema J, Peltenburg LT, van der Eb AJ, Jochemsen AG.

Cancer Res. 2001 Mar 1;61(5):1839-42.

8.

Hdmx stabilizes Mdm2 and p53.

Stad R, Ramos YF, Little N, Grivell S, Attema J, van Der Eb AJ, Jochemsen AG.

J Biol Chem. 2000 Sep 8;275(36):28039-44.

9.

Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass.

Weerwind PW, Maessen JG, van Tits LJ, Stad RK, Fransen EJ, de Jong DS, Penn OC.

J Thorac Cardiovasc Surg. 1995 Dec;110(6):1633-41.

10.

Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals.

Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, Schuuring E, Kluin PM.

Blood. 1995 May 1;85(9):2528-36.

PMID:
7727781
11.

Enigmas in the pathogenesis of IgA nephropathy.

van Es LA, van den Wall Bake AW, Stad RK, van den Dobbelsteen ME, Bogers MJ, Daha MR.

Contrib Nephrol. 1995;111:169-75; discussion 175-6. Review. No abstract available.

PMID:
7758338
12.
13.

Differential regulatory effects of adenosine on cytokine release by activated human monocytes.

Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA.

J Immunol. 1994 Nov 1;153(9):4159-68.

PMID:
7930619
14.

Hereditary C6 deficiency in a strain of PVG/c rats.

Leenaerts PL, Stad RK, Hall BM, Van Damme BJ, Vanrenterghem Y, Daha MR.

Clin Exp Immunol. 1994 Sep;97(3):478-82.

15.

Current views on structure and function of endothelial adhesion molecules.

Stad RK, Buurman WA.

Cell Adhes Commun. 1994 Jul;2(3):261-8. Review. No abstract available.

PMID:
7530152
16.

Complement depletion abolishes IgA-mediated glomerular inflammation in rats.

Stad RK, van Gijlswijk-Janssen DJ, van Es LA, Daha MR.

Exp Nephrol. 1994 May-Jun;2(3):182-9.

PMID:
7922271
17.

Role of liver endothelial and Kupffer cells in clearance of human C1q in rats.

Coremans IE, Bogers WM, Stad RK, van der Voort EA, Prins FA, van Rooijen N, Breedveld FC, Daha MR.

Eur J Immunol. 1993 Aug;23(8):1942-7.

PMID:
8344357
18.

Detection of the t(14;18) translocation in frozen and formalin-fixed tissue.

Limpens J, Beelen M, Stad R, Haverkort M, van Krieken JH, van Ommen GJ, Kluin PM.

Diagn Mol Pathol. 1993 Jun;2(2):99-107.

PMID:
8269284
19.

An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies.

Stad RK, Bruijn JA, van Gijlswijk-Janssen DJ, van Es LA, Daha MR.

Clin Exp Immunol. 1993 Jun;92(3):514-21.

20.

Both Kupffer cells and liver endothelial cells play an important role in the clearance of IgA and IgG immune complexes.

Bogers WM, Stad RK, Van Es LA, Daha MR.

Res Immunol. 1992 Feb;143(2):219-24. Review. No abstract available.

PMID:
1574651
21.

In vivo activation of complement by IgA in a rat model.

Stad RK, Bogers WM, Thoomes-van der Sluys ME, Van Es LA, Daha MR.

Clin Exp Immunol. 1992 Jan;87(1):138-43.

22.
23.

Deposition of IgA is associated with macrophage influx in the kidney of rats.

Stad RK, Bogers WM, Muizert Y, van Es LA, Daha MR.

Scand J Immunol. 1991 Jul;34(1):81-9.

PMID:
2068534
24.

Kupffer cell depletion in vivo results in clearance of large-sized IgA aggregates in rats by liver endothelial cells.

Bogers WM, Stad RK, Janssen DJ, Prins FA, van Rooijen N, van Es LA, Daha MR.

Clin Exp Immunol. 1991 Jul;85(1):128-36.

25.

Complement enhances the clearance of large-sized soluble IgA aggregates in rats.

Bogers WM, Stad RK, Janssen DJ, Rits M, Bazin H, Van Es LA, Daha MR.

Eur J Immunol. 1991 May;21(5):1093-9.

PMID:
2037008
26.

Immunoglobulin A: interaction with complement, phagocytic cells and endothelial cells.

Bogers WM, Stad RK, van Es LA, Daha MR.

Complement Inflamm. 1991;8(5-6):347-58. Review.

PMID:
1802552
27.

Enrichment and selection of hybrid hybridomas by Percoll density gradient centrifugation and fluorescent-activated cell sorting.

Koolwijk P, Rozemuller E, Stad RK, De Lau WB, Bast BJ.

Hybridoma. 1988 Apr;7(2):217-25.

PMID:
3372003

Supplemental Content

Support Center